Rio de Janeiro, Brazil, April 22, 2007 The International Society of Nephrology (ISN) today announced Eduardo Slatopolsky, Joseph Friedman Professor of Renal Diseases in Medicine, Washington University School of Medicine (St. Louis, Missouri - USA) as the 2007 winner of the ISN Amgen International Prize for Therapeutic Advancement in Nephrology.
Established in 2003, the ISN Amgen International Prize recognizes those who have increased the understanding and treatment of kidney disease through basic or clinical scientific research, leading to therapeutic advances. This year's prize specifically recognizes Slatopolsky's pioneering experimental research in mineral metabolism which has undoubtedly improved the lives of patients with renal failure around the world.
With over 400 publications in basic and clinical sciences related to mineral metabolism a testament to his outstanding contribution to the field, Slatopolsky has dedicated his entire career to the study of kidney disease with a 30 year record of major scientific achievements.
Receiving the prestigious prize during the 2007 Donald Seldin Plenary Lecture at the World Congress of Nephrology on April 22, Eduardo Slatopolsky expressed his thanks to ISN, Amgen and recognized the contribution of his laboratory members,
"I am deeply moved to be the recipient of this award of the ISN it is a unique privilege that I have been selected for the ISN Amgen International Prize for Therapeutic Advancement in Nephrology. I accepted on behalf of my colleagues, with tremendous gratitude for having been selected as recipient."'
"Amgen congratulates Eduardo Slatopolsky on this important recognition by the ISN," said Robert Brenner, M.D. Executive Director Nephrology Medical Affairs. "Dr. Slatopolsky has made broad contributions to our understanding of the pathophysiology of secondary hyperparathyroidism, hyperphosphatemia and vitamin D biology. His efforts have driven treatmen
Contact: Amanda Wren
International Society of Nephrology